Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00955097 · ClinicalTrials.gov registry record · Phase 1
Evaluation of Intra-operative Ultrasound Contrast Enhancement in the Evaluation of Liver Tumors
A Phase 1 study, sponsored by University of Louisville.
- Terminated
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT00955097 is a Phase 1 study that was terminated before completion, run by University of Louisville. The registered enrollment target is 6 participants.
The verdict
NCT00955097, a Phase 1 study, was terminated before completion, sponsored by University of Louisville.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
The primary purpose of this study is to demonstrate the safety and effectiveness of using an intra-operative ultrasound contrast agent(Definity®) for the identification of known liver tumors.
Interventions
- DRUG Definity®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2008-05 |
| Est. Completion | 2010-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00955097
The ClinicalTrials.gov registry entry for NCT00955097 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Definity® is the first listed.
NCT00955097 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00955097 about?
NCT00955097 is a clinical study titled "Evaluation of Intra-operative Ultrasound Contrast Enhancement in the Evaluation of Liver Tumors". The primary purpose of this study is to demonstrate the safety and effectiveness of using an intra-operative ultrasound contrast agent(Definity®) for the identification of known liver tumors.
What is the current status of trial NCT00955097?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2008-05. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00955097?
The interventions under investigation include: Definity® (DRUG).
Who is sponsoring clinical trial NCT00955097?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.